Patents by Inventor Jonathan David Charlesworth
Jonathan David Charlesworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240123223Abstract: A technique for neurostimulation therapy is disclosed, particularly for patients suffering from Restless Legs Syndrome (RLS) or Periodic Limb Movement Disorder (PLMD). The technique can involve initiating a high-frequency electrostimulation signal during a specific time period associated with the patient's transition from sleep to wakefulness. The signal can be delivered to a target location on the patient at a frequency ranging from 500 Hz to 15,000 Hz and can be controlled toward parameters below the threshold that would wake the patient, while effectively mitigating the symptoms of RLS or PLMD.Type: ApplicationFiled: December 22, 2023Publication date: April 18, 2024Inventors: Jonathan David Charlesworth, Stephanie Kayla Rigot
-
Publication number: 20240123227Abstract: A technique for neurostimulation therapy is disclosed, particularly for patients suffering from Restless Legs Syndrome (RLS) or Periodic Limb Movement Disorder (PLMD). The technique can involve initiating a high-frequency electrostimulation signal during a specific time period associated with the patient's transition from sleep to wakefulness. The signal can be delivered to a target location on the patient at a frequency ranging from 500 Hz to 15,000 Hz and can be controlled toward parameters below the threshold that would wake the patient, while effectively mitigating the symptoms of RLS or PLMD.Type: ApplicationFiled: December 22, 2023Publication date: April 18, 2024Inventors: Jonathan David Charlesworth, Stephanie Kayla Rigot
-
Publication number: 20240057937Abstract: Approaches described herein can capture an audio signal using at least one microphone while a user of an electronic device is determined to be asleep. At least one audio frame can be determined from the audio signal. The at least one audio frame represents a spectrum of frequencies detected by the at least one microphone over some period of time. One or more sounds associated with the at least one audio frame can be determined. Sleep-related information can be generated. The information identifies the one or more sounds as potential sources of sleep disruption.Type: ApplicationFiled: September 14, 2023Publication date: February 22, 2024Inventors: Hao-Wei Su, Logan Niehaus, Conor Joseph Heneghan, Jonathan David Charlesworth, Subramaniam Venkatraman, Shelten Gee Jao Yuen
-
Patent number: 11878166Abstract: A system for monitoring or treating RLS or PLMD can include or use a leg-wearable electrostimulation device for acquiring auxiliary data from a subject at a first leg location at which the device is worn, the first leg-wearable electrostimulation device including or using a first neurostimulation delivery device, an impedance sensor configured for determining an impedance via the first and second skin electrodes, and an auxiliary sensor configured for detecting the auxiliary data of the first leg location at which the device is worn.Type: GrantFiled: November 15, 2022Date of Patent: January 23, 2024Assignee: NOCTRIX HEALTH, INC.Inventors: John Craig Colborn, Jonathan David Charlesworth, Shriram Raghunathan
-
Patent number: 11872041Abstract: Physiological variables, metrics, biomarkers, and other data points can be used, in connection with a non-invasive wearable device, to screen for, and predict, mental health issues and cognitive states. In addition to metrics such as heart rate, sleep data, activity level, gamification data, and the like, information such as text message and email data, as well as vocal data obtained through a phone and/or a microphone, may be analyzed, provided user authorization. Applying predictive modeling, one or more of the monitored metrics can be correlated with mental states and disorders. Identified patterns can be used to update the predictive models, such as via machine learning-trained models, as well as to update individual event predictions. Information about the mental state predictions, and updates thereto, can be surfaced to the user accordingly.Type: GrantFiled: December 6, 2021Date of Patent: January 16, 2024Assignee: FITBIT, INC.Inventors: Conor Joseph Heneghan, Alexander Statan, Jonathan David Charlesworth
-
Patent number: 11793453Abstract: Approaches described herein can capture an audio signal using at least one microphone while a user of an electronic device is determined to be asleep. At least one audio frame can be determined from the audio signal. The at least one audio frame represents a spectrum of frequencies detected by the at least one microphone over some period of time. One or more sounds associated with the at least one audio frame can be determined. Sleep-related information can be generated. The information identifies the one or more sounds as potential sources of sleep disruption.Type: GrantFiled: June 2, 2020Date of Patent: October 24, 2023Assignee: Fitbit, Inc.Inventors: Hao-Wei Su, Logan Niehaus, Conor Joseph Heneghan, Jonathan David Charlesworth, Subramaniam Venkatraman, Shelten Gee Jao Yuen
-
Publication number: 20230149711Abstract: A system for monitoring or treating RLS or PLMD can include or use a leg-wearable electrostimulation device for acquiring auxiliary data from a subject at a first leg location at which the device is worn, the first leg-wearable electrostimulation device including or using a first neurostimulation delivery device, an impedance sensor configured for determining an impedance via the first and second skin electrodes, and an auxiliary sensor configured for detecting the auxiliary data of the first leg location at which the device is worn.Type: ApplicationFiled: November 15, 2022Publication date: May 18, 2023Inventors: John Craig Colborn, Jonathan David Charlesworth, Shriram Raghunathan
-
Publication number: 20220218993Abstract: Techniques to help improve efficiency or effectiveness of treating a disorder such as RLS or PLMD, such as by issuing neural electrostimulations to a particular patient, while varying one or more amplitude parameters (e.g., at least one of electrostimulation current amplitude, electrostimulation voltage amplitude, or electrostimulation pulsewidth duration). A corresponding patient-subjective or patient-objective response can be observed. A characteristic electrostimulation intensity relationship can be generated, for example, based on the determined respective at least one of RLS or PLMD response indication threshold amplitude parameters and the plurality of corresponding neural electrostimulation durations.Type: ApplicationFiled: January 25, 2022Publication date: July 14, 2022Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Publication number: 20220143393Abstract: Systems and methods for treating a patient having symptoms of restless legs syndrome (RLS) or Periodic Limb Movement Disorder (PLMD) using high-frequency stimulation by applying a high-frequency pulsed electrostimulation therapy signal to a femoral nerve or a branch thereof. An electrostimulation device can include or use clonus detection circuitry can be used such as to monitor for a presence of clonic activity during treatment. Feedback from the clonus detection circuitry can be used to select or modify a therapy parameter of the electrostimulation device such as to help mitigate clonic muscle activity during therapy.Type: ApplicationFiled: January 24, 2022Publication date: May 12, 2022Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Publication number: 20220088372Abstract: Systems and methods for treating a patient having symptoms of restless legs syndrome (RLS) or Periodic Limb Movement Disorder (PLMD) using high-frequency stimulation by applying a high-frequency pulsed electrostimulation therapy signal to a peroneal nerve or a branch thereof, where the therapy signal is above a motor threshold of a muscle innervated by the peroneal nerve or branch thereof. Surface EMG (sEMG) response to neurostimulation can be used to evaluate patient responsivity to neurostimulation, or to evaluate neurostimulation efficacy, such as to compare various neurostimulation parameter settings and to select between such settings to meet or balance between one or more goals. The sEMG response can be obtained with the muscle at rest, or during muscle activation.Type: ApplicationFiled: July 30, 2021Publication date: March 24, 2022Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Patent number: 11266836Abstract: Techniques to help improve efficiency or effectiveness of treating a disorder such as RLS or PLMD, such as by issuing neural electrostimulations to a particular patient, while varying one or more amplitude parameters (e.g., at least one of electrostimulation current amplitude, electrostimulation voltage amplitude, or electrostimulation pulsewidth duration). A corresponding patient-subjective or patient-objective response can be observed. A characteristic electrostimulation intensity relationship can be generated, for example, based on the determined respective at least one of RLS or PLMD response indication threshold amplitude parameters and the plurality of corresponding neural electrostimulation durations.Type: GrantFiled: April 27, 2021Date of Patent: March 8, 2022Assignee: NOCTRIX HEALTH, INC.Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Patent number: 11229369Abstract: Approaches described herein can determine one or more breathing phase patterns over a period of time using audio data captured by at least one microphone. The audio data can include one or more snores. A breathing phase pattern included within the period of time can be determined based at least in part on sensor data captured by one or more sensors in the electronic device. A determination can be made that a first breathing phase pattern represented by the audio data and a second breathing phase pattern represented by the sensor data are correlated. A determination can be made that the first breathing phase pattern represented by the audio data and the second breathing phase pattern represented by the sensor data both correspond to a user wearing the electronic device.Type: GrantFiled: June 4, 2019Date of Patent: January 25, 2022Assignee: Fitbit IncInventors: Hao-Wei Su, Logan Niehaus, Conor Joseph Heneghan, Jonathan David Charlesworth, Subramaniam Venkatraman, Shelten Gee Jao Yuen
-
Patent number: 11191466Abstract: Physiological variables, metrics, biomarkers, and other data points can be used, in connection with a non-invasive wearable device, to screen for, and predict, mental health issues and cognitive states. In addition to metrics such as heart rate, sleep data, activity level, gamification data, and the like, information such as text message and email data, as well as vocal data obtained through a phone and/or a microphone, may be analyzed, provided user authorization. Applying predictive modeling, one or more of the monitored metrics can be correlated with mental states and disorders. Identified patterns can be used to update the predictive models, such as via machine learning-trained models, as well as to update individual event predictions. Information about the mental state predictions, and updates thereto, can be surfaced to the user accordingly.Type: GrantFiled: June 28, 2019Date of Patent: December 7, 2021Assignee: Fitbit Inc.Inventors: Conor Joseph Heneghan, Alexander Statan, Jonathan David Charlesworth
-
Patent number: 11103691Abstract: Systems and methods for treating a patient having symptoms of restless legs syndrome (RLS) or Periodic Limb Movement Disorder (PLMD) using high-frequency stimulation by applying a high-frequency pulsed electrostimulation therapy signal to a peroneal nerve or a branch thereof, where the therapy signal is above a motor threshold of a muscle innervated by the peroneal nerve or branch thereof. Surface EMG (sEMG) response to neurostimulation can be used to evaluate patient responsivity to neurostimulation, or to evaluate neurostimulation efficacy, such as to compare various neurostimulation parameter settings and to select between such settings to meet or balance between one or more goals. The sEMG response can be obtained with the muscle at rest, or during muscle activation.Type: GrantFiled: October 2, 2020Date of Patent: August 31, 2021Assignee: Noctrix Health, Inc.Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Publication number: 20210260379Abstract: Techniques to help improve efficiency or effectiveness of treating a disorder such as RLS or PLMD, such as by issuing neural electrostimulations to a particular patient, while varying one or more amplitude parameters (e.g., at least one of electrostimulation current amplitude, electrostimulation voltage amplitude, or electrostimulation pulsewidth duration). A corresponding patient-subjective or patient-objective response can be observed. A characteristic electrostimulation intensity relationship can be generated, for example, based on the determined respective at least one of RLS or PLMD response indication threshold amplitude parameters and the plurality of corresponding neural electrostimulation durations.Type: ApplicationFiled: April 27, 2021Publication date: August 26, 2021Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Publication number: 20210100998Abstract: Systems and methods for treating a patient having symptoms of restless legs syndrome (RLS) or Periodic Limb Movement Disorder (PLMD) using high-frequency stimulation by applying a high-frequency pulsed electrostimulation therapy signal to a peroneal nerve or a branch thereof, where the therapy signal is above a motor threshold of a muscle innervated by the peroneal nerve or branch thereof. Surface EMG (sEMG) response to neurostimulation can be used to evaluate patient responsivity to neurostimulation, or to evaluate neurostimulation efficacy, such as to compare various neurostimulation parameter settings and to select between such settings to meet or balance between one or more goals. The sEMG response can be obtained with the muscle at rest, or during muscle activation.Type: ApplicationFiled: October 2, 2020Publication date: April 8, 2021Inventors: Jonathan David Charlesworth, Shriram Raghunathan
-
Publication number: 20200383633Abstract: Approaches described herein can capture an audio signal using at least one microphone while a user of an electronic device is determined to be asleep. At least one audio frame can be determined from the audio signal. The at least one audio frame represents a spectrum of frequencies detected by the at least one microphone over some period of time. One or more sounds associated with the at least one audio frame can be determined. Sleep-related information can be generated. The information identifies the one or more sounds as potential sources of sleep disruption.Type: ApplicationFiled: June 2, 2020Publication date: December 10, 2020Inventors: Hao-Wei Su, Logan Niehaus, Conor Joseph Heneghan, Jonathan David Charlesworth, Subramaniam Venkatraman, Shelten Gee Jao Yuen
-
Publication number: 20200383581Abstract: Approaches described herein can determine one or more breathing phase patterns over a period of time using audio data captured by at least one microphone. The audio data can include one or more snores. A breathing phase pattern included within the period of time can be determined based at least in part on sensor data captured by one or more sensors in the electronic device. A determination can be made that a first breathing phase pattern represented by the audio data and a second breathing phase pattern represented by the sensor data are correlated. A determination can be made that the first breathing phase pattern represented by the audio data and the second breathing phase pattern represented by the sensor data both correspond to a user wearing the electronic device.Type: ApplicationFiled: June 4, 2019Publication date: December 10, 2020Inventors: Hao-Wei Su, Logan Niehaus, Conor Joseph Heneghan, Jonathan David Charlesworth, Subramaniam Venkatraman, Shelten Gee Jao Yuen